NANO MRNA Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-940.00
-832.00
-777.00
-1,308.00
-1,879.00
-2,832.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
49.00
297.00
212.00
104.00
229.00
48.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-816.00
-401.00
-585.00
-1,087.00
-1,752.00
-1,247.00
Cash Flow from Investing Activities
2,261.00
587.00
793.00
1,207.00
-244.00
-871.00
Cash Flow from Financing Activities
2,222.00
-568.00
3.00
0.00
1,145.00
-11.00
Net Cash Inflow / Outflow
3,713.00
-378.00
265.00
180.00
-794.00
-2,125.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
45.00
4.00
54.00
59.00
56.00
4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of NANO MRNA Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-940.753
2864
-3,804.00
-132.85%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
49.079
-985
1,034.00
104.98%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-816.672
3393
-4,209.00
-124.07%
Cash Flow from Investing Activities
2261.576
-5547
7,808.00
140.77%
Cash Flow from Financing Activities
2222.415
6192
-3,970.00
-64.11%
Net Cash Inflow / Outflow
3713.152
4088
-375.00
-9.17%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
45.833
50
-5.00
-8.33%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -103.35% vs 31.36% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-816.67
-401.62
-103.35%






